Example: Heart Attack

Search clinical trials for: Diazoxide

Total 29 results

    • NCT03566511
      Suspended
      Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
      Conditions: Diabetes Mellitus, Type 2; Glucose, High Blood; Glucose Metabolism Disorders (Including Diabetes Mellitus)
    • NCT01488136
      Completed
      Use of Diazoxide in Acute Hypoglycaemia
      Conditions: Type 1 Diabetes
    • NCT00994149
      Unknown status
      Diazoxide In the Management Of Hypoglycemic Neonates
      Conditions: Infant, Newborn, Diseases; Pregnancy in Diabetics; Infant, Diabetic Mother; Hypoglycemia; Infant, Large for Gestational Age
    • NCT00892073
      Completed
      Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy
      Conditions: Hypothalamic Obesity
    • NCT00688857
      Completed
      Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated Formulations
      Conditions: Hypertriglyceridemia
    • NCT00151684
      Completed
      Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men
      Conditions: Obesity; Hyperinsulinism
    • NCT02893618
      Unknown status
      A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)
      Conditions: Prader-Willi Syndrome
    • NCT01211860
      Completed
      Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects
      Conditions: Hypertriglyceridmia
    • NCT00131755
      Completed
      Efficacy of Diazoxide in Type 1 Diabetes
      Conditions: Diabetes Mellitus, Type 1
    • NCT00306683
      Completed
      Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions
      Conditions: Hypothalamic-pituitary Lesions; Craniopharyngiomas
    • NCT00683774
      Completed
      Insulin and Polycystic Ovary Syndrome
      Conditions: PCOS
    • NCT00901823
      Withdrawn
      Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
      Conditions: Hypertriglyceridemia
    • NCT01211847
      Completed
      Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia
      Conditions: Hypertriglyceridemia; Dyslipidemia
    • NCT00696475
      Completed
      Diazoxide Choline in Hypertriglyceridemia
      Conditions: Hypertriglyceridemia
    • NCT02034071
      Completed
      Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
      Conditions: Prader-Willi Syndrome
    • NCT00631033
      Completed
      DZX Mediated Insulin Suppression in Obese Men
      Conditions: Obesity
    • NCT03685773
      Suspended
      The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
      Conditions: Diabetes Mellitus, Type 2; Glucose, High Blood; Glucose Metabolism Disorders
    • NCT02049385
      Terminated
      Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?
      Conditions: Depression
    • NCT03540758
      Suspended
      Regulation of Endogenous Glucose Production by Central KATP Channels
      Conditions: Type 2 Diabetes Mellitus; Glucose Metabolism Disorders; Glucose, High Blood
    • NCT01028846
      Active, not recruiting
      Central Mechanisms That Regulate Glucose Metabolism in Humans
      Conditions: Type 2 Diabetes; Glucose Metabolism Disorders; Glucose, High Blood
    • NCT02779257
      Withdrawn
      Pasireotide Treatment for Neuroendocrine Tumor
      Conditions: Gastro-enteropancreatic Neuroendocrine Tumor
    • NCT03608163
      Suspended
      Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
      Conditions: Diabetes Mellitus, Type 1; Hypoglycemia; Hypoglycemia Unawareness
    • NCT00973271
      Withdrawn
      Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
      Conditions: Hypertriglyceridemia
    • NCT03440814
      Completed
      A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
      Conditions: Prader-Willi Syndrome
    • NCT03714373
      Active, not recruiting
      Open-Label Extension Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
      Conditions: Prader-Willi Syndrome
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations